Dosimetric comparison of stereotactic MR-guided radiation therapy (SMART) and HDR brachytherapy boost in cervical cancer

The standard of care in locally advanced cervical cancer (LACC) is concomitant chemoradiotherapy followed by high-dose-rate brachytherapy (HDR-BT). Although previous studies compared HDR-BT with stereotactic body radiotherapy (SBRT), there is scarce data regarding the dosimetric outcomes of stereotactic MR-guided adaptive radiation therapy (SMART) boost in lieu of HDR-BT.

https://www.brachyjournal.com/article/S1538-4721(23)01644-6/fulltext?rss=yes

Source: Brachytherapy - November 23, 2023 Category: Cancer & Oncology Authors: Neris Dincer, Gamze Ugurluer, Teuta Zoto Mustafayev, Anatolia Serkizyan, Gokhan Aydin, G örkem Güngör, Bulent Yapici, Banu Atalar, Enis Özyar Source Type: research